Valion Bio, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · San Antonio, TX
VBIO chart
What traders are saying about $VBIO
Latest postsValion Bio, Inc. news
- Valion Bio announces preferred stock and warrant sales totaling $4.77 million
Investing.com Nigeria ·
- Form 8K Valion Bio Inc For: 27 October By Investing.com
Investing.com Nigeria ·
- SA drug developer to consider acquisition offers
The Business Journals ·
- Valion Bio, Inc. (VBIO) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Valion Bio receives unsolicited bids for CDMO subsidiary By Investing.com
Investing.com Nigeria ·
- Valion Bio Weighs Sale of Velocity Bioworks After Unsolicited Takeover Interest
Minichart ·
- Valion Bio weighs sale of CDMO unit after unsolicited interest
StreetInsider ·
- Valion Bio Enters Preliminary Discussions Regarding Velocity Bioworks
TradingView ·
- Valion Bio Weighs Strategic Options After Unsolicited Interest in Velocity Bioworks
TradingView ·
- Valion Bio Receives Unsolicited Acquisition Interest in Velocity Bioworks; Weighs Strategic Options
Yahoo Finance ·
- Outside parties have inquired about buying Valion Bio’s manufacturing arm. No sale has been agreed.
Stock Titan ·
- Valion Bio adds $4.72M in preferred stock, but only $1.5M is fresh cash
Dealroom ·
Valion Bio, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | $780,000 | $1.2M | $1.8M |
| Net income | -$8.9M | -$5.7M | -$8.2M | -$10.1M |
| Diluted EPS | – | $-19.68 | $-176.80 | $-104.32 |
| Total assets (year end) | $31.6M | $2.8M | $5.2M | $5.9M |
| Cash and equivalents (year end) | $12.6M | $2.0M | $3.4M | $3.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 8-KFORM 8-K
- 8-KFORM 8-K
- 8-KFORM 8-K
- DEF 14ADEFINITIVE PROXY STATEMENT
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 8-KFORM 8-K
- 8-KCURRENT REPORT
- 8-KFORM 8-K
- 8-KFORM 8-K
- 8-KCURRENT REPORT
About Valion Bio, Inc.
- Ticker
- VBIO (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Antonio, TX
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1787740
- Former names
- Tivic Health Systems, Inc.
Frequently asked questions
What exchange is Valion Bio, Inc. listed on?
Valion Bio, Inc. trades on the Nasdaq under the ticker symbol VBIO.
What industry is Valion Bio, Inc. in?
Valion Bio, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Valion Bio, Inc. headquartered?
Valion Bio, Inc.'s business address on file with the SEC is in San Antonio, TX.
When does Valion Bio, Inc.'s fiscal year end?
Valion Bio, Inc.'s fiscal year ends on December 31.
How much revenue did Valion Bio, Inc. report?
Valion Bio, Inc. reported $780,000 in revenue for calendar year 2024, according to its SEC filings.